Publication | Open Access

Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel

Medicinal ChemistryUrologyOncologyAbiraterone And/or DocetaxelMedicinePharmacotherapyPrior TreatmentAnti-cancer AgentProstatic DiseasePharmacology